$PODC
PodcastOne, Inc. Stock $podc

$podc Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067375 Filed on August 15, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$10.52M	$10.64M
YoY Change	23.76%	22.04%
Cost Of Revenue	$9.057M	$8.222M
YoY Change	43.13%	24.94%
Gross Profit	$1.459M	$2.415M
YoY Change	-32.73%	13.11%
Gross Profit Margin	13.87%	22.7%
Selling, General & Admin	$2.666M	$2.170M
YoY Change	40.17%	-14.09%
% of Gross Profit	182.73%	89.86%
Research & Development	$28.00K	$27.00K
YoY Change	-34.88%	-58.46%
% of Gross Profit	1.92%	1.12%
Depreciation & Amortization	$100.0K	$86.00K
YoY Change	0.0%	14.67%
% of Gross Profit	6.85%	3.56%
Operating Expenses	$2.694M	$2.197M
YoY Change	38.51%	-15.21%
Operating Profit	-$1.426M	$193.0K
YoY Change	-820.2%	-140.12%
Interest Expense	$654.0K	$1.593M
YoY Change	-52.68%
% of Operating Profit		825.39%
Other Income/Expense, Net	-$9.447M	-$403.0K
YoY Change	1342.29%
Pretax Income	-$10.87M	-$210.0K
YoY Change	2279.21%	-56.34%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$10.87M	-$210.0K
YoY Change	2279.21%	-56.34%
Net Earnings / Revenue	-103.39%	-1.97%
Basic Earnings Per Share	-$0.52	-$0.01
Diluted Earnings Per Share	-$0.52	-$0.01
COMMON SHARES
Basic Shares Outstanding	20.00M shares	20.00M shares
Diluted Shares Outstanding		20.00M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$491.0K	$470.0K
YoY Change	-88.11%
Cash & Equivalents	$491.0K	$468.0K	$3.562M
Short-Term Investments
Other Short-Term Assets	$967.0K	$1.130M
YoY Change	42.21%
Inventory
Prepaid Expenses
Receivables	$9.693M	$8.790M	$6.876M
Other Receivables	$0.00	$900.0K	$1.500M
Total Short-Term Assets	$11.15M	$10.39M	$11.44M
YoY Change	-6.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$236.0K	$229.0K	$242.0K
YoY Change	-5.6%
Goodwill	$12.04M	$12.04M	$12.04M
YoY Change
Intangibles	$2.821M	$707.0K	$732.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$17.26M	$16.82M	$16.78M
YoY Change	-7.23%
TOTAL ASSETS
Total Short-Term Assets	$11.15M	$10.39M	$11.44M
Total Long-Term Assets	$17.26M	$16.82M	$16.78M
Total Assets	$28.42M	$27.21M	$28.23M
YoY Change	-7.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.377M	$1.960M
YoY Change	-33.48%
Accrued Expenses	$6.742M	$6.100M
YoY Change	68.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$5.630M
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.88M	$20.22M	$21.11M
YoY Change	-40.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$256.0K		$0.00
YoY Change
Total Long-Term Liabilities	$256.0K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.88M	$20.22M	$21.11M
Total Long-Term Liabilities	$256.0K	$0.00	$0.00
Total Liabilities	$11.13M	$20.22M	$21.11M
YoY Change	-38.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.00M	-$12.88M	-$12.67M
YoY Change
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.28M	$6.993M	$7.119M
YoY Change
Total Liabilities & Shareholders Equity	$28.42M	$27.21M	$28.23M
YoY Change	-7.05%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$10.87M	-$210.0K
YoY Change	2279.21%	-56.34%
Depreciation, Depletion And Amortization	$100.0K	$86.00K
YoY Change	0.0%	14.67%
Cash From Operating Activities	$631.0K	-$46.00K
YoY Change	-113.45%	-105.3%
INVESTING ACTIVITIES
Capital Expenditures	$602.0K	$48.00K
YoY Change	903.33%	-11.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$602.0K	-$48.00K
YoY Change	903.33%	-11.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-$3.000M
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	631.0K	-$46.00K
Cash From Investing Activities	-602.0K	-$48.00K
Cash From Financing Activities	0.000	-$3.000M
Net Change In Cash	29.00K	-$3.094M
YoY Change	-98.68%	-480.1%
FREE CASH FLOW
Cash From Operating Activities	$631.0K	-$46.00K
Capital Expenditures	$602.0K	$48.00K
Free Cash Flow	$29.00K	-$94.00K
YoY Change	-100.61%	-111.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	333-269028
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	COURTSIDE GROUP, INC.
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2503373
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	335 N. Maple Drive
CY2023Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 127
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Beverly Hills
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90210
CY2023Q2	dei	City Area Code CityAreaCode	(310)
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	858-0888
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q2	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20000000	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	468000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3562000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8794000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	6876000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1126000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1006000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	10388000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	11444000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	229000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	242000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	12041000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	12041000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	707000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	732000	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	3846000	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	3768000	usd
CY2023Q2	us-gaap	Assets Assets	27211000	usd
CY2023Q1	us-gaap	Assets Assets	28227000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8058000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6898000	usd
CY2023Q2	us-gaap	Bridge Loan BridgeLoan	5630000	usd
CY2023Q1	us-gaap	Bridge Loan BridgeLoan	7155000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3577000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4767000	usd
CY2023Q2	cour	Related Party Payable RelatedPartyPayable	2953000	usd
CY2023Q1	cour	Related Party Payable RelatedPartyPayable	2288000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20218000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21108000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20000000	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19869000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19785000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12876000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12666000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6993000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	7119000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27211000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28227000	usd
CY2023Q2	us-gaap	Revenues Revenues	10637000	usd
CY2022Q2	us-gaap	Revenues Revenues	8716000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8222000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6581000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1250000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1590000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	920000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	936000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25000	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10444000	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9197000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	193000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-481000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1593000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1190000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-403000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-210000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-481000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-210000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-481000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20000000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147984230	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	7119000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	84000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-210000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6993000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13085000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	286000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-481000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12890000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-210000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-481000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	86000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	84000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	286000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1475000	usd
CY2023Q2	cour	Change In Fair Value Of Bifurcated Embedded Derivatives ChangeInFairValueOfBifurcatedEmbeddedDerivatives	-1190000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1968000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1199000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	120000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-69000	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	588000	usd
CY2022Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	283000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1160000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-563000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	868000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54000	usd
CY2023Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-3000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3094000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	814000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3562000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1103000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	468000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1917000	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 — Organization and Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Organization</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Courtside Group, Inc. (“we,” “us,” “our”, the “Company” or “PodcastOne”) is a Delaware corporation headquartered in Beverly Hills, California and is doing business as PodcastOne. The Company is a leading podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website (www.podcastone.com), its PodcastOne app, Apple Podcasts, Spotify, Amazon Music and more.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was incorporated in the State of Delaware on February 25, 2014, and is a wholly owned subsidiary of LiveOne, Inc. (“LiveOne”) On July 1, 2020, LiveOne through its wholly owned subsidiary, LiveXLive PodcastOne, Inc., acquired the Company. Acquisitions are included in the Company’s financial statements from the date of the acquisition. The Company uses purchase accounting for its acquisitions, which results in all assets and liabilities of acquired businesses being recorded at their estimated fair values on the acquisition dates. In connection with the acquisition, the accounts of the Company were adjusted using the push down basis of accounting to recognize the allocation of the net assets acquired which was determined to be $16.1 million. In accordance with the push down basis of accounting, the Company’s net assets were adjusted to their fair values as of the date of the acquisition based upon an independent appraisal. The Company has two wholly owned subsidiaries, Courtside, LLC, a Delaware limited liability company, and PodcastOne Sales, LLC, a California limited liability company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Basis of Presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The results of operations and financial position of the Company are consolidated with LiveOne’s financial statements and that these financial statements have been derived as if the Company had operated on a standalone basis during the three months ended June 30, 2023 and 2022. The amounts recorded for related party transactions with LiveOne may not be considered arm’s length transactions and therefore, the financial statements may not necessarily reflect the Company’s results of operations, financial position and cash flows had the Company engaged in such transactions with an unrelated third party during the three months ended June 30, 2023 and 2022. Accordingly, the Company’s historical financial information is not necessarily indicative of what the Company’s results of operations, financial position and cash flows will be in the future, if and when the Company contracts at arm’s length with unrelated third parties for services they receive from LiveOne. The results for the three months ended June 30, 2023 are not necessarily indicative of the results expected for the full fiscal year ending March 31, 2024 (“fiscal 2024”). The condensed consolidated balance sheet as of March 31, 2023 has been derived from the Company’s audited balance sheet included in the Company’s Special Financial Report under cover of the facing page of an Annual Report on Form 10-K, filed with the United States Securities and Exchange Commission (the “SEC”) on June 29, 2023 (the “Special Financial Report”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The interim unaudited condensed consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with Article 10 of Regulation S-X. They do not include all the information and footnotes required by GAAP for complete audited financial statements. Therefore, these consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Special Financial Report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Going Concern and Liquidity</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s principal sources of liquidity have historically been its debt issuances and its cash and cash equivalents (which cash and cash equivalents amounted to $0.5 million as of June 30, 2023). The Company has an accumulated deficit of $12.9 million and a working capital deficiency of $9.0 million as of June 30, 2023. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date that these financial statements are filed. The Company’s condensed consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is looking for additional financing sources to attempt to secure additional interim financing by end of October 2023 after the completion of the Company’s proposed listing on a national securities exchange, which is needed to continue its current level of business operations and satisfy its current obligations, unless such financing is provided by LiveOne, if at all. In the absence of additional sources of liquidity, management anticipates that existing cash resources will not be sufficient to meet current operating and liquidity needs beyond August 2024. There is no assurance that management will be able to obtain additional liquidity or be successful in raising additional funds or that such required funds, if available, or that LiveOne will provide any financing to the Company, if at all, or that any such financing will be available on attractive terms or that it will not have a significant dilutive effect on the Company’s existing stockholders. In addition, management is unable to determine at this time whether any of these potential sources of liquidity will be adequate to support the Company’s future business operations. While the Company does not currently anticipate delays or hindrances to its current business operations and initiatives schedule due to liquidity constraints, without additional funding the Company may not be able to continue its current level of business operations in the future. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Accordingly, the financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Principles of Consolidation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Acquisitions are included in the Company’s condensed consolidated financial statements from the date of the acquisition. The Company uses purchase accounting for its acquisitions, which results in all assets and liabilities of acquired businesses being recorded at their estimated fair values on the acquisition dates. All intercompany balances and transactions have been eliminated in consolidation.</p>
CY2023Q2	us-gaap	Assets Net AssetsNet	16100000	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	500000	usd
CY2023Q2	cour	Working Capital WorkingCapital	9000000	usd
CY2023Q2	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Use of Estimates</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, the fair value of the Company’s equity-based compensation awards and convertible debt and debt instruments, fair values of derivatives, and contingencies. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. Given the overall uncertainty surrounding the COVID-19 pandemic, there is a reasonable possibility that actual results could differ from those estimates and such differences could be material to the financial position and results of operations, specifically in assessing when the collectability of revenue related consideration is probable, and the impairment assessment of goodwill, indefinite lived assets or long-lived assets that are depreciated or amortized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
CY2022Q2	us-gaap	Depreciation Depreciation	100000	usd
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	100000000	shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	10000000	shares
CY2023Q2	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Revenue Recognition Policy</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for a contract with a customer when an approved contract exists, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and the collectability of substantially all of the consideration is probable. Revenue is recognized when the Company satisfies its obligation by transferring control of the goods or services to its customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The Company uses the expected value method to estimate the value of variable consideration on advertising contracts to include in the transaction price and reflect changes to such estimates in periods in which they occur. Variable consideration for these services is allocated to and recognized over the related time period such advertising services are rendered as the amounts reflect the consideration the Company is entitled to and relate specifically to the Company’s efforts to satisfy its performance obligation. The amount of variable consideration included in revenue is limited to the extent that it is probable that the amount will not be subject to significant reversal when the uncertainty associated with the variable consideration is subsequently resolved.</p>
CY2023Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	4100000	usd
CY2022Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1300000	usd
CY2023Q2	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	100000	usd
CY2022Q2	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	100000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	707000	usd
CY2022Q4	us-gaap	Preferred Stock Per Share Amounts Of Preferred Dividends In Arrears PreferredStockPerShareAmountsOfPreferredDividendsInArrears	0.00001
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	468000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1917000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	9028000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7062000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	234000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	186000	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	8794000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	6876000	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	900000	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1500000	usd
CY2023Q2	cour	Bridge Loan Proceeds BridgeLoanProceeds	8800000	usd
CY2023Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Concentration of Credit Risk</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to any significant credit risk with respect to such cash and cash equivalents.</p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	758000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	710000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	529000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	468000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	229000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	242000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1782000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1075000	usd
CY2022Q2	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	707000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1782000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1050000	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	732000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	76000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	101000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	101000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	101000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	101000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	227000	usd
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1963000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1541000	usd
CY2023Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	3685000	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	3039000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2410000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2318000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	8058000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6898000	usd
CY2023Q2	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	(i) the price equal to $60.0 million divided by the aggregate number of shares of the Company’s common stock outstanding immediately prior to the closing of a Qualified Financing or Qualified Event, as applicable (assuming full conversion or exercise of all convertible and exercisable securities of the Company then outstanding, subject to certain exceptions), and (ii) 70% of the offering price of the shares (or whole units, as applicable) in the Qualified Financing or 70% of the initial listing price of the shares on a national securities exchange in the Qualified Event, as applicable. Each holder of the PC1 Notes (other than the Company) may at such holder’s option require the Company to redeem up to 45% of the principal amount of such holder’s PC1 Notes (together with accrued interest thereon, but excluding the OID), in aggregate up to $3,000,000 for all of the PC1 Notes (other than those held by the Company), immediately prior to the completion of a Qualified Financing or a Qualified Event, as applicable, with such redemption to be made pro rata to the redeeming holders of the PC1 Notes (the “Optional Redemption”). Upon a Purchaser’s redemption of any PC1 Notes pursuant to the Optional Redemption right, then a portion of such Purchaser’s PC1 Warrants shall be forfeited and cancelled in accordance with the following formula: for each $0.001 million of the principal amount of the PC1 Notes redeemed, PC1 Warrants to purchase 100% of the Warrant Shares issued per $0.001 million of the principal amount of the PC1 Notes shall be immediately forfeited and cancelled.
CY2023Q2	cour	Debt Instrument Live One Description DebtInstrumentLiveOneDescription	(i) not to effect a Qualified Financing or a Qualified Event, as applicable, unless immediately following such event LiveOne owns no less than 66% of the Company’s equity, unless in either case otherwise permitted by the written consent of the holders of the majority of the PC1 Notes (excluding LiveOne) (the “Majority Noteholders”) and LiveOne’s senior lender, as applicable, (ii) that until a Qualified Financing or a Qualified Event, as applicable, is consummated, LiveOne guaranteed the repayment of the PC1 Notes when due (other than the Bridge Notes issued to LiveOne) and any interest or other fees due thereunder, and (iii) that if the Company has not consummated a Qualified Financing or a Qualified Event, as applicable, by February 15, 2023, March 15, 2023 or April 15, 2023, as applicable, unless in either case permitted by the written consent of the Majority Noteholders, LiveOne shall be required to redeem $1,000,000 of the then outstanding PC1 Notes pro rata from the PC1 Notes holders (other than the PC1 Notes issued to LiveOne) by the tenth calendar day of each month immediately following such respective date, up to an aggregate redemption of $3,000,000 over the course of such three months, each of which shall be distributed to the holders of the PC1 Notes (other than LiveOne) on a prorated basis (the “Early Redemption”).
CY2023Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1000000	usd
CY2023Q2	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	2000000	usd
CY2023Q2	cour	Debt Instrument Not Required To Repay Of Principal Amount DebtInstrumentNotRequiredToRepayOfPrincipalAmount	3000000	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	3000000	usd
CY2023Q2	us-gaap	Obligation With Joint And Several Liability Arrangement Amount Outstanding ObligationWithJointAndSeveralLiabilityArrangementAmountOutstanding	2600000	usd
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	110000000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.742	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.715	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0417	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0486	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	2.38
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	2.64
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.24
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.64
CY2023Q2	us-gaap	Debt Securities Trading Unrealized Gain DebtSecuritiesTradingUnrealizedGain	400000	usd
CY2023Q2	cour	Fair Value Debt Instrument Of Redemption Liability FairValueDebtInstrumentOfRedemptionLiability	1100000	usd
CY2023Q3	cour	Debt Instrument Amortized To Interest Expense DebtInstrumentAmortizedToInterestExpense	5800000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1400000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	200000	usd
CY2020Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	15000000	usd
CY2023Q2	us-gaap	Other Notes Payable OtherNotesPayable	3800000	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	3700000	usd
CY2023Q2	us-gaap	Contractual Obligation ContractualObligation	1800000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	7000000	usd
CY2022Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	9800000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	1	pure
CY2023Q2	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05	pure
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17600000	shares
CY2023Q2	cour	Stock Options Expire Term StockOptionsExpireTerm	P10Y
CY2023Q2	cour	Unrecognized Cost UnrecognizedCost	100000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	240000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.84
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	240000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.84
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	128750	shares
CY2023Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	2.65
CY2023Q2	cour	Weightedaverage Contractual Term WeightedaverageContractualTerm	P8Y1M2D
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	300000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	200000	usd
CY2023Q2	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P0Y8M1D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	262500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	262500	shares
CY2023Q2	cour	Fair Value Of Restricted Stock FairValueOfRestrictedStock	100000	usd
CY2022Q2	cour	Fair Value Of Restricted Stock FairValueOfRestrictedStock	400000	usd
CY2023Q2	us-gaap	Stockholders Equity Note Impact Of Conversion Of Contingently Convertible Securities On Diluted Earnings Per Share StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare	Spin-Out, the Company shall have the authority to issue up to 110,000,000 shares, consisting of 100,000,000 shares of the Company’s common stock and 10,000,000 shares of the Company’s preferred stock, $0.00001 par value per share (the “preferred stock”).
CY2023Q2	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	3577000	usd
CY2023Q1	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	4767000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	4767000	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	-1190000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	3577000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q2	us-gaap	Interest Expense InterestExpense		usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147984230	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20000000	shares
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022Q2	cour	Change In Fair Value Of Bifurcated Embedded Derivatives ChangeInFairValueOfBifurcatedEmbeddedDerivatives		usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q2	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001940177
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q2	dei	Security12b Title Security12bTitle	NA
CY2023Q2	dei	Trading Symbol TradingSymbol	NA

Files In Submission

Name	View Source	Status
0001213900-23-067375-index-headers.html	Edgar Link	pending
0001213900-23-067375-index.html	Edgar Link	pending
0001213900-23-067375.txt	Edgar Link	pending
0001213900-23-067375-xbrl.zip	Edgar Link	pending
cour-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_courtside.htm	Edgar Link	pending
f10q0623ex31-2_courtside.htm	Edgar Link	pending
f10q0623ex32-1_courtside.htm	Edgar Link	pending
f10q0623ex32-2_courtside.htm	Edgar Link	pending
f10q0623_courtside.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
cour-20230630_def.xml	Edgar Link	unprocessable
cour-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_courtside_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cour-20230630_lab.xml	Edgar Link	unprocessable
cour-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODC
PodcastOne, Inc. Stock $podc

2023 Q3 Form 10-Q Financial Statement

#000121390023067375 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODC PodcastOne, Inc. Stock $podc

2023 Q3 Form 10-Q Financial Statement

#000121390023067375 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODC
PodcastOne, Inc. Stock $podc